Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / / Cánceres Orofaríngeos / Recursos de NCI
|
NCI CANCERLIT® Search: Mouth Cancer - October 2001
Simultaneous treatment of multiple primary cancers of the oral cavity and other sites. Lip cancer in South Australia, 1977-1996. [Gingival multiple hamartoma syndrome] Cytostatic effect of inostamycin, an inhibitor of cytidine ... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - September 2001
Table of Contents[Mandibulotomy for cancer of the oral cavity and oropharynx: functional and carcinologic outcome in 107 cases][Teratoma of the rhinopharynx and the infratemporal fossa in neonates: report of 3 cases]Alcohol dehydrogenase 3... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - October 2001
Treatment of subtotal medial rectus myectomy complicating functional endoscopic sinus surgery. Treatment of subtotal medial rectus myectomy complicating functional endoscopic sinus surgery. [Smell dysfunction in nasal and paranasal sinus... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - September 2001
Table of ContentsRisk of multiple primary cancers in nasal cancer patients.A case of solitary nasal schwannoma.[Frontal ethmoid metastases of prostatic carcinoma. Report of one case and review of the literature][Basocellular carcinoma and... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - October 2001
Photodynamic-induced apoptosis of human nasopharyngeal carcinoma cells using Hypocrellins. Effect of photodynamic therapy (PDT) on the expression of pro-apoptotic protein Bak in nasopharyngeal carcinoma (NPC). Advanced hypopharyngeal... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - September 2001
Table of Contents[Mandibulotomy for cancer of the oral cavity and oropharynx: functional and carcinologic outcome in 107 cases]Alcohol dehydrogenase 3 genotype is not associated with risk of squamous cell carcinoma of the oral cavity and... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - October 2001
[Lymphatic metastases in the parotid region from malignant skin neoplasm of the head: considerations for surgical treatment based on personal High-dose-rate endobronchial brachytherapy in endobronchial metastatic malignant chondroid... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - September 2001
Table of Contents[Isolated facial palsy and occult adenoid cystic carcinoma of the parotid]Pathology quiz case: plasmacytoid variety of myoepithelioma of minor salivary gland.Adenocarcinoma of the salivary gland metastatic to the pituitary... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - April 2002
Study of the vascular pattern in oral lichen planus. A comparative study of oral lichen planus and leukoplakia in two Argentine populations. [Craniofacial resection for advanced malignant tumors in oral and maxillofacial region] Strain... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - August 2002
The unexplained survival of cells in oral cancer: what is the role of p53? Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas. Rising trends in oral cancer... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - February 2002
N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. Preventing and controlling oral and pharyngeal cancer. Recommendations from a National Strategic Planning Conference.... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - January 2002
Metastatic malignant melanoma in the hand muscle--a case report. Free flap reconstructions in the management of oral and pharyngeal cancer. Metastatic renal cell carcinoma presenting as an oral tumor. Differences in EBNA2 and LMP-1 carboxy... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - July 2002
[Oral hairy leukoplakia: histopathologic features of subclinical stage] Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared [Factors affecting local and... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - June 2002
Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. ... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - March 2002
Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Comparison of reliability between the modified groin flap and the forearm flap in oral reconstruction. Granulocytic... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - May 2002
Management of the neck in N0 squamous cell carcinoma of the oral cavity. Peripheral calcifying odontogenic cyst. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - October 2002
Clinical significance of interleukin-6 and interleukin-6 receptor expressions in oral squamous cell carcinoma. The pattern of expression of Mn and Cu-Zn superoxide dismutase varies among squamous cell cancers of the lung, larynx, and oral... |
|
|
NCI CANCERLIT® Search: Mouth Cancer - September 2002
Uncommon cancers are also important. Indian doctors defend "unethical" anticancer drug trial. Clinical research. Hopkins reviews investment in Indian cancer drug trial. Clinical research. India acts on flawed cancer drug trials. Altered... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - April 2002
Persistent nodule on the nose. Maxillectomy. Esthesioneuroblastoma: a meta-analysis and review. [Inverted papilloma: endoscopic versus external surgery. Apropos of 28 cases] Nasal glioma in an infant. Adenocarcinoma of the paranasal sinuses:... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - August 2002
Growth hormone-secreting pituitary adenoma confined to the sphenoid sinus associated with a normal-sized empty sella. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - February 2002
Nasal paraganglioma. A case report. Symmetrical ethmoidal metastases from ductal carcinoma of the breast, suggesting transcribrosal spread. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - January 2002
Reconstruction of nasal alar defects. Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells. Analysis of proteoglycan gene messages in human nasal mucosa and nasal polyp... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - July 2002
[Tumor of the nose] [Primary melanoma of the nasal and paranasal sinus mucosa] Secondary extramedullary plasmacytoma involving the pancreas. Primary neuroblastoma of the maxillary sinus. Fluticasone propionate downregulates nasal fibroblast... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - June 2002
A composite nasolabial flap for an entire ala reconstruction. [Fernand Widal syndrome: apropos of 2 cases] The effect of growth factors on the proliferation and differentiation of human nasal gland cells. Management of advanced... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - March 2002
Ophthalmic complications after surgery for nasal and sinus polyposis. Malignant lymphoma of the maxillary sinus manifesting as a persistent toothache. A long-term follow-up study of nasal polyp patients after simple polypectomies. [Skull... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - May 2002
[The monthly interesting case No. 52. Plexiform ameloblastoma of the maxillary sinus] [Long term results in adenoidcystic carcinoma] Analysis of human papillomavirus in schneiderian papillomas as compared to chronic sinusitis and normal... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - October 2002
Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Rare mesenchymal lesions: Hamartoma of the chest wall and juvenile active ossifying fibroma in siblings. Malignant tumors of the... |
|
|
NCI CANCERLIT® Search: Paranasal Sinus and Nasal Cavity Cancer - September 2002
[Aetiology of Angiofibromas: Reflection on their Specific Vascular Component] Repositioning accuracy: comparison of a noninvasive head holder with thermoplastic mask for fractionated radiotherapy and a case report. [Sinus-nasal... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - April 2002
Extension as a prognostic factor in oropharyngeal cancer: largest mucosal dimension compared with number of (sub)sites involved. Re: Carinci et al. Extension as a prognostic factor in oro-pharyngeal cancer: largest mucosal dimension... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - August 2002
Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells. Oral and pharyngeal cancer: knowledge and opinions of dentists in British Columbia and Nova Scotia. Oral and pharyngeal cancer: practices and opinions of... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - February 2002
Preventing and controlling oral and pharyngeal cancer. Recommendations from a National Strategic Planning Conference. Latent membrane protein-1 of Epstein-Barr virus inhibits cell growth and induces sensitivity to cisplatin in... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - January 2002
Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Magnetic resonance imaging (MRI) controlled outcome of side effects caused by ionizing radiation, treated with 780 nm-diode laser -- Voice... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - July 2002
[Study on the correlation between the expression of protein p53 at stage III nasopharyngeal carcinoma and its biological behavior, prognosis, p53 [Pedicled pectoralis major musculocutaneous flaps] Local recurrence in head and neck cancer:... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - June 2002
Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission. 10-minute consultation: rhinitis. Article is unhelpful. [Diagnostic evaluation of nasopharyngeal carcinoma: role of Epstein-Barr ... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - March 2002
Dental hygienists' knowledge, opinions, and practices related to oral and pharyngeal cancer risk assessment. Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. A comparative study of undifferentiated... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - May 2002
[Brachytherapy with (192)Iridium in the treatment of recurrent nasopharyngeal carcinoma] Brush biopsy for detection of nasopharyngeal cancer. [cDNA expression array in the differential expression profiles of p53 regulated genes in... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - October 2002
Nutrition and pharyngeal cancer: results from a case-control study in Spain. Do Ki67, S-phase, S + G2M and DNA ploidy, evaluated by flow cytometry, reveal locoregional metastasis in oral cavity and oropharynx carcinomas? Correlation of... |
|
|
NCI CANCERLIT® Search: Pharyngeal Cancer - September 2002
Sonographic characterisation of radiation-induced carotid artery stenosis. The incidence of oropharyngeal cancer in Taiwan: an endemic betel quid chewing area. Smokeless tobacco use and cancer of the upper respiratory tract. Monitoring... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - April 2002
[The application of color Doppler ultrasound technique in diagnosing the lumps of salivary gland] Surgical management of parotid disease. The management of minor salivary gland tumors of the oral cavity. Fine needle aspiration diagnosis of... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - August 2002
Collagenous spherulosis in epithelial-myoepithelial carcinoma of the parotid gland. Histological and immunohistological study of a case. Duchenne muscular dystrophy-rhabdomyosarcoma, ichthyosis vulgaris/acute monoblastic leukemia:... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - February 2002
Plexiform neurofibroma of the submandibular salivary gland in a child. Hyalinizing clear cell carcinoma of the oral cavity and of the parotid gland. A rare tumor of salivary gland origin: hyalinizing clear cell carcinoma. Mandibular and... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - January 2002
Acinic cell carcinoma arising in pleomorphic adenoma of parotid gland. Expression of epidermal growth factor in salivary adenoid cystic carcinoma. Binding patterns of 51 monoclonal antibodies to peptide and carbohydrate epitopes of the... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - July 2002
Long-standing mucosa-associated lymphoid tissue lymphoma of the parotid gland: CT and MR imaging findings. [Metastasis in submandibular gland from a leiomyosarcoma of the uterus] Chronic eosinophilic pneumonia associated with T-cell lymphoma.... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - June 2002
Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland. [Myoepithelioma of the parotid gland] Parotidectomy in the treatment of aggressive cutaneous malignancies. Synchronous... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - March 2002
Obligatory requirement of sulfation for P-selectin binding to human salivary gland carcinoma Acc-M cells and breast carcinoma ZR-75-30 Clinical and immunohistochemical analyses of parotid gland tumors. Microsurgical selective removal of benign... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - May 2002
[Long term results in adenoidcystic carcinoma] Outcome of curative management of malignant tumours of the parotid gland. Recurrent pleomorphic adenoma of the parotid gland with cervical metastasis. Acinar phenotypes in salivary pleomorphic... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - October 2002
Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features. Salivary gland B cell lymphoproliferative disorders in Sjogren's syndrome present a restricted... |
|
|
NCI CANCERLIT® Search: Salivary Gland Cancer - September 2002
Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in salivary gland tumors. Sebaceous lymphadenoma of the lip: report of a case of minor salivary gland origin. Parotid gland metastasis from renal cell... |
|
|
NCI/PDQ® Health professionals: Hypopharyngeal Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Hypopharyngeal CancerCellular Classification of Hypopharyngeal CancerStage Information for Hypopharyngeal CancerDefinitions of TNMTreatment Option OverviewStage I Hypopharyngeal CancerCurrent Clinical... |
|
|
NCI/PDQ® Health professionals: Lip and Oral Cavity Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Lip and Oral Cavity CancerRelated SummariesCellular Classification of Lip and Oral Cavity CancerStage Information for Lip and Oral Cavity CancerDefinitions of TNMTreatment Option OverviewStage I Lip and... |
|
|
NCI/PDQ® Health professionals: Nasopharyngeal Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Nasopharyngeal CancerAnatomyRisk FactorsSigns and SymptomsDiagnostic TestsPrognosisFollow-upCellular Classification of Nasopharyngeal CancerStage Information for Nasopharyngeal CancerDefinitions of... |
|
|
NCI/PDQ® Health professionals: Oral Cancer Prevention (PDQ®)
TABLE OF CONTENTS OverviewWho is at Risk?Factors associated with increased risk of oral cancerTobacco useAlcohol useHPV infectionSun exposureInterventions Associated With a Decreased Risk of Oral CancerAvoidance of tobaccoInterventions With... |
|
|
NCI/PDQ® Health professionals: Oral Cancer Screening (PDQ®)
TABLE OF CONTENTS OverviewBenefitsHarms Description of the EvidenceBackgroundIncidence and mortalityRisk factorsEvidence of Benefit Associated With Screening Adjunctive techniques to visual examinationEvidence of Harm Associated With... |
|
|
NCI/PDQ® Health professionals: Oropharyngeal Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Oropharyngeal CancerCellular Classification of Oropharyngeal CancerStage Information for Oropharyngeal CancerDefinitions of TNMTreatment Option OverviewStage I Oropharyngeal CancerCurrent Clinical... |
|
|
NCI/PDQ® Health professionals: Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Paranasal Sinus and Nasal Cavity CancerCellular Classification of Paranasal Sinus and Nasal Cavity CancerStage Information for Paranasal Sinus and Nasal Cavity CancerDefinitions of TNMTreatment Option... |
|
|
NCI/PDQ® Health professionals: Salivary Gland Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Salivary Gland CancerRelated SummariesCellular Classification of Salivary Gland CancerEpithelial NeoplasmsMucoepidermoid carcinomaAdenoid cystic carcinomaAdenocarcinomasAcinic cell... |
|
|
NCI/PDQ® Pacientes: Cáncer de la glándula salival
TABLE OF CONTENTS Descripción¿Qué es el cáncer de las glándulas salivales?Explicación de los estadiosEstadios de cáncer de las glándulas salivalesEstadio IEstadio IIEstadio IIIEstadio IVAEstadio IVBEstadio... |
|
|
NCI/PDQ® Pacientes: Cáncer de la hipofaringe: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de hipofaringeEstadios del cáncer de hipofaringeCáncer de hipofaringe recidivanteAspectos generales de las opciones de tratamientoOpciones de tratamiento por... |
|
|
NCI/PDQ® Pacientes: Cáncer de la nasofaringe: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de nasofaringeEstadios del cáncer de nasofaringeCáncer de nasofaringe recidivanteAspectos generales de las opciones de tratamientoOpciones de tratamiento por estadio... |
|
|
NCI/PDQ® Pacientes: Cáncer de la orofaringe
TABLE OF CONTENTS Descripción¿Qué es el cáncer de la orofaringe?Explicación de los estadiosEstadios del cáncer de la orofaringeEstadio 0Estadio IEstadio IIEstadio IIIEstadio IVAEstadio IVBEstadio IVCRecurrenteAspectos... |
|
|
NCI/PDQ® Pacientes: Cáncer del labio y la cavidad oral
TABLE OF CONTENTS Descripción¿Qué es el cáncer del labio y la cavidad oral?Explicación de los estadiosEstadios del cáncer del labio y la cavidad oralEstadio IEstadio IIEstadio IIIEstadio IVRecurrenteAspectos generales... |
|
|
NCI/PDQ® Pacientes: Cáncer del seno paranasal y de la cavidad nasal
TABLE OF CONTENTS Descripción¿Qué es el cáncer del seno paranasal y de la cavidad nasal?Explicación de los estadiosEstadios para el cáncer del seno paranasal y de la cavidad nasalEstadios del cáncer del seno... |
|
|
NCI/PDQ® Patients: Hypopharyngeal Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Hypopharyngeal CancerStages of Hypopharyngeal CancerRecurrent Hypopharyngeal CancerTreatment Option OverviewTreatment Options by Stage Stage I Hypopharyngeal CancerStage II Hypopharyngeal CancerStage III... |
|
|
NCI/PDQ® Patients: Lip and Oral Cavity Cancer
TABLE OF CONTENTS DescriptionWhat is cancer of the lip and oral cavity?Stage ExplanationStage of cancer of the lip and oral cavityStage IStage IIStage IIIStage IVRecurrentTreatment Option OverviewHow cancer of the lip and oral cavity is... |
|
|
NCI/PDQ® Patients: Nasopharyngeal Cancer Treatment (PDQ®)
TABLE OF CONTENTS General Information About Nasopharyngeal Cancer Stages of Nasopharyngeal CancerRecurrent Nasopharyngeal CancerTreatment Option OverviewTreatment Options by Stage Stage I Nasopharyngeal CancerStage II Nasopharyngeal CancerStage III... |
|
|
NCI/PDQ® Patients: Oral Cancer Prevention (PDQ®)
TABLE OF CONTENTS Overview of PreventionPreventionPurposes of this summaryOral Cancer PreventionSignificance of oral cancerOral cancer preventionGet More Information From NCIChanges to This Summary (07/23/2007)Questions or Comments About This... |
|
|
NCI/PDQ® Patients: Oral Cancer Screening (PDQ®)
TABLE OF CONTENTS Overview of ScreeningWhat is screening?Purposes of this summaryOral Cancer ScreeningRisk of oral cancerScreening tests for oral cancerGet More Information From NCIChanges to This Summary (07/23/2007)Questions or Comments About This... |
|
|
NCI/PDQ® Patients: Oropharyngeal Cancer
TABLE OF CONTENTS DescriptionWhat is cancer of the oropharynx?Stage ExplanationStages of cancer of the oropharynxStage 0Stage IStage IIStage IIIStage IVAStage IVBStage IVCRecurrentTreatment Option OverviewHow cancer of the oropharynx is... |
|
|
NCI/PDQ® Patients: Paranasal Sinus and Nasal Cavity Cancer
TABLE OF CONTENTS DescriptionWhat is cancer of the paranasal sinus and nasal cavity?Stage ExplanationStages of cancer of the paranasal sinus and nasal cavityStages of cancer of maxillary sinusStage 0Stage IStage IIStage IIIStage IVStages of cancer... |
|
|
NCI/PDQ® Patients: Salivary Gland Cancer
TABLE OF CONTENTS DescriptionWhat is cancer of the salivary gland?Stage ExplanationStages of cancer of the salivary glandStage IStage IIStage IIIStage IVAStage IVBStage IVCRecurrentTreatment Option OverviewHow cancer of the salivary gland is... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer de la glándula salival: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de la glándula salivalSumarios relacionadosClasificación celular del cáncer de la glándula salivalNeoplasias epitelialesCarcinoma mucoepidermoide Carcinoma... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer de la hipofaringe: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de la hipofaringeClasificación celular del cáncer de la hipofaringeInformación sobre los estadios del cáncer de la hipofaringeDefiniciones TNMAspectos generales de... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer de la nasofaringe: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer de la nasofaringeAnatomíaFactores de riesgoSignos y síntomasPruebas diagnósticasPronósticoSeguimientoEnsayos clínicos en cursoClasificación celular del... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer de la orofaringe: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el tratamiento del cáncer de la orofaringeClasificación celular del cáncer de la orofaringeInformación sobre los estadios del cáncer de la orofaringeDefiniciones TNMAspectos... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer del labio y la cavidad oral: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer del labio y la cavidad oralSumarios relacionadosClasificación celular del cáncer del labio y la cavidad oralInformación sobre los estadios del cáncer del labio y la... |
|
|
NCI/PDQ® Profesionales De Salud: Cáncer del seno paranasal y de la cavidad nasal: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el cáncer del seno paranasal y la cavidad nasalClasificación celular del cáncer del seno paranasal y la cavidad nasalInformación sobre los estadios del cáncer del seno... |
What every person should know about screening, learning about your disease and the importance of cllinical research. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

